Despite Philips getting the green light from the U.S. FDA to start repairing and replacing ventilators impacted by the company’s class 1 recall, the FDA exposed a possible safety risk concerning a replacement component.
Read More
ALung Technologies, Inc., a provider of low-flow extracorporeal carbon dioxide removal technologies for treating patients with acute respiratory failure, announces that the U.S. FDA has granted the company De Novo clearance for the Hemolung Respiratory Assist System.
Read More
The U.S. FDA is providing an update related to the June 14, 2021, recall of certain Philips Respironics ventilators, continuous positive airway pressure (CPAP), and bilevel positive airway pressure (BiPAP) machines.
Read More
The size of the global home medical equipment market is estimated to reach $56 billion by 2027, according to a report from Allied Market Research.
Read More
A low-cost ventilator developed by researchers for COVID-19 patients could improve access to these critically needed devices for patients with other respiratory illnesses in developing countries.
Read More